NCT07755774 Psychological Treatment for Adolescents With Self-injury Within Intensive Mental Health Outpatient Services: Randomized Controlled Pilot Trial
| NCT ID | NCT07755774 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karolinska Institutet |
| Condition | Nonsuicidal Self Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-09 |
| Primary Completion | 2028-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-09 with a primary completion date of 2028-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overarching aim of this study is to develop and evaluate a new blended treatment format, which combines face-to-face and digital treatment components, for Emotion Regulation Individual Therapy for Adolescents (ERITA). This brief, transdiagnostic, and blended treatment targeting nonsuicidal self-injury (NSSI) - referred to as blended ERITA - will be specifically designed for adolescents with NSSI and low levels of functioning within intensive outpatient psychiatric services. The specific purpose of this pilot trial is to investigate feasibility in preparation for a larger trial.
Eligibility Criteria
Inclusion Criteria: * 12-17 years old * At least one NSSI episode in the past three months * A parent willing to engage in the parent program * Global functioning corresponding to a rating ≤50 of the Children's Global Assessment Scale (CGAS) Exclusion Criteria: * Immediate suicide risk * Social problems needing immediate intervention (e.g., violence within the family) * Other psychiatric disorder or symptoms requiring immediate treatment (e.g., severe anorexia nervosa, acute psychosis, severe substance abuse) * Ongoing dialectical behavior therapy for adolescents
Contact & Investigator
Olivia Ojala, PhD
PRINCIPAL INVESTIGATOR
Karolinska Institutet
Frequently Asked Questions
Who can join the NCT07755774 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 17 Years, studying Nonsuicidal Self Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07755774 currently recruiting?
Yes, NCT07755774 is actively recruiting participants. Contact the research team at samantha.khoo@ki.se for enrollment information.
Where is the NCT07755774 trial being conducted?
This trial is being conducted at Stockholm, Sweden.
Who is sponsoring the NCT07755774 clinical trial?
NCT07755774 is sponsored by Karolinska Institutet. The principal investigator is Olivia Ojala, PhD at Karolinska Institutet. The trial plans to enroll 40 participants.